Smith & Nephew, a global medical technology business, has named Namal Nawana as its new chief executive officer, it was reported yesterday.
Nawana has joined the company from medical diagnostics company, Alere, where he was also chief executive officer, and managed its USD5.3bn acquisition by Abbott last year. Prior to Alere, Nawana spent more than 15 years at Johnson & Johnson, primarily in its medical devices and diagnostics segment.
Roberto Quarta, chairman of Smith & Nephew, said, 'Namal has the experience as a CEO of a major listed company in the healthcare sector, and has demonstrated that he can energise businesses to deliver better performance and greater value to shareholders.'
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar